Clinical trial
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543 · Vistakon Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00244543 |
|---|---|
| Title | Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis |
| Official title | A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of R89674 0.25% Ophthalmic Solution in Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis |
| Lead sponsor | Vistakon Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | R89674 (generic name not yet established) |
| Enrollment | 110 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2005 |
| First posted | Oct 26, 2005 |
| Last update posted | Sep 27, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: